Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

• Arnon Nagler,
• Myriam Labopin,
• Didier Blaise,
• Anna Maria Raiola,
• Lucia Lopez Corral,
• Stefania Bramanti,
• Simona Sica,
• Mi Kwon,
• Yener Koc,
• Jiri Pavlu,
• Alexander Kulagin,
• Alessandro Busca,
• Arancha Bermúdez Rodríguez,
• Péter Reményi,
• Christoph Schmid,
• Eolia Brissot,
• Jaime Sanz,
• Ali Bazarbachi,
• Sebastian Giebel,
• Fabio Ciceri,
• Mohamad Mohty

Affiliations

Arnon Nagler

Division of Hematology, Sheba Medical Center

Myriam Labopin

EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University

Didier Blaise

Programme de Transplantation and Therapie Cellulaire Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes

Anna Maria Raiola

Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino

Lucia Lopez Corral

Hospital Clínico Servicio de Hematología

Stefania Bramanti

Transplantation Unit Department of Oncology and Haematology, IRCCS Humanitas Research Hospital

Simona Sica

Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS

Mi Kwon

Hematology Hospital GU Gregorio Marañon, Instituto de Investigacion Sanitaria Gregorio Marañon, Medicina UCM

Yener Koc

Bone Marrow Transplant Unit, Medicana International Hospital Istanbul

Jiri Pavlu

Department of Haematology, Hammersmith Hospital, Imperial College

Alexander Kulagin

Raisa Gorbacheva Memorial, Research Institute for Paediatric Oncology, Hematology, and Transplantation, First State Pavlov Medical University of St. Petersburg

Alessandro Busca

SSD Trapianto di Cellule Staminali, AOU Citta’ Della Salute e della Scienza

Arancha Bermúdez Rodríguez

Hospital U. Marqués de Valdecilla, Servicio de Hematología-Hemoterapia

Péter Reményi

Department Hematology and Stem Cell Transplant, Dél-pesti Centrumkórház – Országos Hematológiai és Infektológiai Intézet

Christoph Schmid

Department of Hematology and Oncology, Augsburg University Hospital

Eolia Brissot

Service d’Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, AP-HP, Sorbonne University, and INSERM UMRs 938

Jaime Sanz

Hematology Department, Hospital Universitari Politècnic La Fe

Ali Bazarbachi

Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut

Sebastian Giebel

Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch

Fabio Ciceri

Ospedale San Raffaele, Haematology and BMT

Mohamad Mohty

EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University